Weingartens Invest in Women’s Brain Health Research

Meaningful philanthropy begins with a simple belief: investing in exceptional people and transformative ideas today creates stronger communities tomorrow.

For Aspen-based philanthropists Bryan and Margie Weingarten, that philosophy has shaped years of charitable giving focused on education, healthcare innovation, the arts, and long-term community impact. Their newest philanthropic investment continues that commitment by supporting groundbreaking research at Weill Cornell Medicine that seeks to improve the future of women’s brain health and Alzheimer’s disease research.

As active members of the Dean’s Council and Women’s Health Council at Weill Cornell Medicine, the Weingartens have provided a significant gift to support the development of a Cognitive Neurology Research Data Repository. Led by Dr. Sonja Blum, associate professor of clinical neurology and director of the Memory Disorders and Cognitive Neurology Division, the initiative will create a centralized platform that brings together clinical information, advanced imaging, biomarkers, and research data to accelerate scientific discovery.

The project represents the type of forward-thinking healthcare innovation the Weingartens have long believed deserves philanthropic investment. Rather than funding only today’s needs, their approach focuses on strengthening the infrastructure that allows physicians and researchers to make discoveries capable of improving patient care for decades to come.

“We’ve always believed in supporting professionals who are committed to making a meaningful difference over the long term,” says Margie Weingarten. “Weill Cornell Medicine is bringing together exceptional physicians and scientists to address important challenges in women’s health, and we’re proud to help turn that vision into reality.”

The need has never been greater. Women account for nearly two-thirds of Alzheimer’s disease diagnoses, yet scientists continue working to better understand why women face a disproportionate risk and how emerging diagnostic tools can identify cognitive decline earlier. By supporting the creation of this research repository, the Weingartens are helping provide investigators with the resources necessary to accelerate discoveries that could ultimately improve prevention, diagnosis, and treatment for countless patients.

For Bryan Weingarten, philanthropy has always been rooted in thoughtful leadership and measurable impact. Whether supporting healthcare innovation, educational opportunity, cultural institutions, or nonprofit organizations, he believes meaningful giving should empower experts to solve complex problems while creating benefits that extend far beyond a single project or generation.

That philosophy mirrors the values Bryan has championed throughout his philanthropic work and community involvement, including his commitment to supporting organizations that strengthen people, expand opportunity, and improve quality of life through innovation and collaboration.

“Supporting this work is about helping turn scientific discovery into real-world impact for patients,” Bryan Weingarten says. “That’s what meaningful medical progress looks like.”

This latest investment builds upon the family’s growing support of women’s health initiatives at Weill Cornell Medicine. In 2023, the Weingartens funded a specialized oncology genetics social worker within Dr. Melissa Frey’s Genetics and Personalized Cancer Prevention Program. The position helps individuals and families navigate hereditary cancer risk by providing emotional support, patient advocacy, and guidance throughout the genetic testing process—an investment that recognizes that exceptional healthcare extends beyond medicine alone.

The Weingartens also share a deeply personal connection to the institution. Their daughter, Dr. Sarah Weingarten, completed fellowship training in maternal-fetal medicine at Weill Cornell Medicine, while their future son-in-law, Dr. Sam Kleeman, is beginning his residency in oncology within the Weill Department of Medicine. Those family experiences have reinforced their appreciation for the institution’s commitment to world-class patient care, groundbreaking research, and medical education.

While their philanthropic reach extends nationally, Bryan and Margie Weingarten continue to embrace the values of service, leadership, and community that define Aspen and the Roaring Fork Valley. They believe thriving communities are built through sustained investment in education, healthcare, the arts, and organizations dedicated to improving lives. Their support of pioneering medical research reflects that broader philosophy: meaningful progress happens when visionary institutions are empowered to pursue bold ideas that benefit society as a whole.

As research into women’s brain health continues to evolve, philanthropic leadership will remain an essential catalyst for innovation. Through their partnership with Weill Cornell Medicine, Bryan and Margie Weingarten are helping advance discoveries that may improve outcomes for future generations while demonstrating how thoughtful philanthropy can create lasting impact far beyond a single gift.

Their investment is more than a contribution to one research initiative. It is part of a long-term commitment to supporting innovation, empowering exceptional leaders, and strengthening institutions that improve lives—principles that continue to define Bryan Weingarten’s approach to philanthropy, community leadership, and enduring public service.